Siva1 is a XIAP-interacting protein that balances NFκB and JNK signalling to promote apoptosis

Journal of Cell Science

Volumn 122, Issue 15, 2009, Pages 2651-2661

  Resch, Ulrike ^a   Schichi, Yvonne M ^a   Winsauer, Gabriele ^a   Gudi, Radhika ^b   Prasad, Kanteti ^b   de Martin, Rainer ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apoptosis; JNK; Siva1; TAK1; XIAP

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SIVA1; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CASPASE 3; CELLS, CULTURED; EMBRYO, MAMMALIAN; FIBROBLASTS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MICE; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 69549113279     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.049940     Document Type: Article

References (44)

1. Akiba, H., Nakano, H., Nishinaka, S., Shindo, M., Kobata, T., Atsuta, M., Morimoto, C., Ware, C. F., Malinin, N. L., Wallach, D. et al. (1998). CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/ c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J. Biol. Chem. 273, 13353-13358.
2. Asselin, E., Mills, G. B. and Tsang, B. K. (2001). XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res. 61, 1862-1868.
3. Birkey Reffey, S., Wurthner, J. U., Parks, W. T., Roberts, A. B. and Duckett, C. S. (2001). X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling. J. Biol. Chem. 276, 26542-26549.
4. Boatright, K. M. and Salvesen, G. S. (2003). Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15, 725-731.
5. Bubici, C., Papa, S., Pham, C. G., Zazzeroni, F. and Franzoso, G. (2006). The NF-kappaB-mediated control of ROS and JNK signaling. Histol. Histopathol. 21, 69-80.
6. Chen, Y. R. and Tan, T. H. (2000). The c-Jun N-terminal kinase pathway and apoptotic signaling (review). Int. J. Oncol. 16, 651-662.
7. Chu, F., Borthakur, A., Sun, X., Barkinge, J., Gudi, R., Hawkins, S. and Prasad, K. V. (2004). The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis 9, 83-95.
8. Conte, D., Liston, P., Wong, J. W., Wright, K. E. and Korneluk, R. G. (2001). Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation. Proc. Natl. Acad. Sci. USA 98, 5049-5054.
9. Creagh, E. M., Murphy, B. M., Duriez, P. J., Duckett, C. S. and Martin, S. J. (2004). Smac/Diablo antagonizes ubiquitin ligase activity of inhibitor of apoptosis proteins. J. Biol. Chem. 279, 26906-26914.
10. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
11. Fadeel, B. and Orrenius, S. (2005). Apoptosis: a basic biological phenomenon with wideranging implications in human disease. J. Intern. Med. 258, 479-517.
12. Frelin, C., Imbert, V., Bottero, V., Gonthier, N., Samraj, A. K., Schulze-Osthoff, K., Auberger, P., Courtois, G. and Peyron, J. F. (2008). Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO. Cell Death Differ. 15, 152-160.
13. Gudi, R., Barkinge, J., Hawkins, S., Chu, F., Manicassamy, S., Sun, Z., Duke-Cohan, J. S. and Prasad, K. V. (2006). Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD). Oncogene 25, 3458-3462.
14. Henke, A., Launhardt, H., Klement, K., Stelzner, A., Zell, R. and Munder, T. (2000). Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J. Virol. 74, 4284-4290.
15. Hofer-Warbinek, R., Schmid, J. A., Stehlik, C., Binder, B. R., Lipp, J. and de Martin, R. (2000). Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275, 22064-22068.
16. Jacobs, S. B., Basak, S., Murray, J. I., Pathak, N. and Attardi, L. D. (2007). Siva is an apoptosis-selective p53 target gene important for neuronal cell death. Cell Death Differ. 14, 1374-1385.
17. Karin, M. and Lin, A. (2002). NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
18. Karin, M. and Greten, F. R. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759.
19. Kaur, S., Wang, F., Venkatraman, M. and Arsura, M. (2005). X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). J. Biol. Chem. 280, 38599-38608.
20. Lei, K., Nimnual, A., Zong, W. X., Kennedy, N. J., Flavell, R. A., Thompson, C. B., Bar-Sagi, D. and Davis, R. J. (2002). The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol. Cell. Biol. 22, 4929-4942.
21. Lewis, J., Burstein, E., Reffey, S. B., Bratton, S. B., Roberts, A. B. and Duckett, C. S. (2004). Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis. J. Biol. Chem. 279, 9023-9029.
22. Lin, F. T., Lai, Y. J., Makarova, N., Tigyi, G. and Lin, W. C. (2007). The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. J. Biol. Chem. 282, 37759-37769.
23. Liston, P., Fong, W. G. and Korneluk, R. G. (2003). The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22, 8568-8580.
24. Lu, M., Lin, S. C., Huang, Y., Kang, Y. J., Rich, R., Lo, Y. C., Myszka, D., Han, J. and Wu, H. (2007). XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell 26, 689-702.
25. Nestler, M., Martin, U., Hortschansky, P., Saluz, H. P., Henke, A. and Munder, T. (2006). The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22. Mol. Cell Biochem. 287, 147-155.
26. Padanilam, B. J., Lewington, A. J. and Hammerman, M. R. (1998). Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney Int. 54, 1967-1975.
27. Prasad, K. V., Ao, Z., Yoon, Y., Wu, M. X., Rizk, M., Jacquot, S. and Schlossman, S. F. (1997). CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA 94, 6346-6351.
28. Py, B., Slomianny, C., Auberger, P., Petit, P. X. and Benichou, S. (2004). Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J. Immunol. 172, 4008-4017.
29. Py, B., Bouchet, J., Jacquot, G., Sol-Foulon, N., Basmaciogullari, S., Schwartz, O., Biard-Piechaczyk, M. and Benichou, S. (2007). The Siva protein is a novel intracellular ligand of the CD4 receptor that promotes HIV-1 envelope-induced apoptosis in T-lymphoid cells. Apoptosis 12, 1879-1892.
30. Resch, U., Schichl, Y. M., Sattler, S. and de Martin, R. (2008). XIAP regulates intracellular ROS by enhancing antioxidant gene expression. Biochem. Biophys. Res. Commun. 375, 156-161.
31. Rigaud, S., Fondaneche, M. C., Lambert, N., Pasquier, B., Mateo, V., Soulas, P., Galicier, L., Le Deist, F., Rieux-Laucat, F., Revy, P. et al. (2006). XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444, 110-114.
32. Sabapathy, K., Kallunki, T., David, J. P., Graef, I., Karin, M. and Wagner, E. F. (2001). c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med. 193, 317-328.
33. Sanna, M. G., da Silva Correia, J., Ducrey, O., Lee, J., Nomoto, K., Schrantz, N., Deveraux, Q. L. and Ulevitch, R. J. (2002). IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol. Cell. Biol. 22, 1754-1766.
34. Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K., Takeuchi, O. and Akira, S. (2005). Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095.
35. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M. and Ben-Neriah, Y. (1994). JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736.
36. Ventura, J. J., Cogswell, P., Flavell, R. A., Baldwin, A. S., Jr and Davis, R. J. (2004). JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev. 18, 2905-2915.
37. Ventura, J. J., Hubner, A., Zhang, C., Flavell, R. A., Shokat, K. M. and Davis, R. J. (2006). Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell 21, 701-710.
38. Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V. and Boldin, M. P. (1999). Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331-367.
39. Wan, Y. Y., Chi, H., Xie, M., Schneider, M. D. and Flavell, R. A. (2006). The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7, 851-858.
40. Wilkinson, J. C., Wilkinson, A. S., Galban, S., Csomos, R. A. and Duckett, C. S. (2008). Apoptosis-inducing factor is a target for ubiquitination through interaction with XIAP. Mol. Cell. Biol. 28, 237-247.
41. Winsauer, G., Resch, U., Hofer-Warbinek, R., Schichl, Y. M. and de Martin, R. (2008). XIAP regulates bi-phasic NF-kappaB induction involving physical interaction and ubiquitination of MEKK2. Cell. Signal. 20, 2107-2112.
42. Xue, L., Chu, F., Cheng, Y., Sun, X., Borthakur, A., Ramarao, M., Pandey, P., Wu, M., Schlossman, S. F. and Prasad, K. V. (2002). Siva-1 binds to and inhibits BCL-X(L)-mediated rotection against UV radiation-induced apoptosis. Proc. Natl. Acad. Sci. USA 99, 6925-6930.
43. Yamaguchi, K., Nagai, S., Ninomiya-Tsuji, J., Nishita, M., Tamai, K., Irie, K., Ueno, N., Nishida, E., Shibuya, H. and Matsumoto, K. (1999). XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J. 18, 179-187.
44. Yamamoto, K., Ichijo, H. and Korsmeyer, S. J. (1999). BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 19, 8469-8478.